Frazier Life Sciences Management, L.P.
41 holdingsFiling period: 2026-06-30Current AUM: $3.94Bestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | MIRM | Mirum Pharmaceuticals Inc | 7.68M | $899.1M | $639.5M | 16.25% | -- | 2026-06-30 |
| 2 | — | Newamsterdam Pharma Company | 18.09M | $613.0M | $613.0M | 15.58% | +1.15M | 2026-06-30 |
| 3 | ERAS | Erasca Inc | 24.98M | $457.5M | $374.4M | 9.51% | +300.0K | 2026-06-30 |
| 4 | MBX | Mbx Biosciences Inc | 6.65M | $367.2M | $334.5M | 8.50% | -- | 2026-06-30 |
| 5 | ARQT | Arcutis Biotherapeutics Inc | 9.87M | $258.9M | $314.1M | 7.98% | -- | 2026-06-30 |
| 6 | TRVI | Trevi Therapeutics Inc | 9.94M | $185.4M | $124.3M | 3.16% | -100 | 2026-06-30 |
| 7 | KRYS | Krystal Biotech Inc | 481.3K | $178.9M | $151.0M | 3.84% | -- | 2026-06-30 |
| 8 | MAZE | Maze Therapeutics Inc | 5.03M | $150.2M | $156.4M | 3.97% | +465.6K | 2026-06-30 |
| 9 | PHAT | Phathom Pharmaceuticals Inc | 12.47M | $135.3M | $74.1M | 1.88% | -- | 2026-06-30 |
| 10 | PVLA | Palvella Therapeutics Inc NE | 882.4K | $134.8M | $111.4M | 2.83% | -- | 2026-06-30 |
| 11 | BBIO | Bridgebio Pharma Inc | 1.55M | $115.3M | $105.5M | 2.68% | -1,900,000 | 2026-06-30 |
| 12 | IRON | Disc Medicine Inc | 1.35M | $99.1M | $105.2M | 2.67% | -- | 2026-06-30 |
| 13 | CYTK | Cytokinetics Inc | 1.16M | $98.8M | $70.4M | 1.79% | -- | 2026-06-30 |
| 14 | DYN | Dyne Therapeutics Inc | 3.15M | $70.0M | $49.6M | 1.26% | -- | 2026-06-30 |
| 15 | ASND | Ascendis Pharma A/S | 225.2K | $60.1M | $55.2M | 1.40% | +91.8K | 2026-06-30 |
| 16 | SVRA | Savara Inc | 9.72M | $59.9M | $43.9M | 1.12% | -- | 2026-06-30 |
| 17 | PBLS | Parabilis Medicines Inc | 1.92M | $52.6M | $48.1M | 1.22% | -- | 2026-06-30 |
| 18 | AURA | Aura Biosciences Inc | 7.10M | $50.4M | $43.9M | 1.11% | +2.00M | 2026-06-30 |
| 19 | ACHV | Achieve Life Science Inc | 7.61M | $49.7M | $49.8M | 1.27% | -- | 2026-06-30 |
| 20 | VOR | Vor Biopharma Inc | 2.54M | $46.8M | $46.6M | 1.18% | -- | 2026-06-30 |
| 21 | ALLO | Allogene Therapeutics Inc | 22.45M | $46.7M | $27.2M | 0.69% | +18.65M | 2026-06-30 |
| 22 | TARS | Tarsus Pharmaceuticals Inc | 728.6K | $45.9M | $51.0M | 1.30% | -- | 2026-06-30 |
| 23 | BCRX | Biocryst Pharmaceuticals Inc | 4.01M | $40.1M | $31.6M | 0.80% | -- | 2026-06-30 |
| 24 | — | Alkermes PLC | 700.6K | $36.7M | $36.7M | 0.93% | -- | 2026-06-30 |
| 25 | ACAD | Acadia Pharmaceuticals Inc | 1.44M | $36.4M | $28.4M | 0.72% | -- | 2026-06-30 |
← Scroll →
Page 1 of 2